Early evidence suggests GLP-1s were linked to lower risks of developing substance use disorders — from alcohol to opioids — and to fewer overdoses and deaths in people with existing addictions.

Patients who are prescribed higher daily doses of the medication buprenorphine for opioid use disorder are significantly more ...

In a clinical trial, a research team found that administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder (OUD) during pregnancy led to higher rates of ...

In a clinical trial supported by the National Institutes of Health (NIH), a research team found that administering weekly injectable extended-release ...

In a clinical trial supported by the National Institutes of Health (NIH), a research team found that administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder ...

Extended-release buprenorphine was an effective treatment for pregnant women with opioid use disorder (OUD) and safe for their babies, according to an open-label randomized trial.

The New Hampshire Attorney General’s office required Dartmouth Health to fund and operate an addiction treatment center at ...

Advocates point to a Philadelphia program as a model for statewide grief support services that could be funded with opioid settlement funds.

HARRISBURG, PA — Pennsylvania officials approved more than $42 million in state and federal grants Wednesday to support public safety programs, including services for gun violence victims, county ...